Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 5, 2017
Insider Transaction Report
Form 4
KAVANAGH SARAH B
Director
Transactions
- Award
Common Stock, no par value
2017-05-05+25,406→ 39,864 total
Footnotes (1)
- [F1]Regular annual Restricted Share Units (RSUs) equal to $250,000 granted to non-employee directors in office on the third trading day following the Annual Meeting of Shareholders based on the closing price of registrant common stock on the date prior to the grant. RSUs represent a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.